Gsa Capital Partners LLP Athersys, Inc Transaction History

Gsa Capital Partners LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.18 - $0.86 $18,595 - $88,845	-103,309 Reduced 17.5%	486,985 $127,000
Q1 2022 May 11, 2022	BUY	$0.6 - $1.06 $19,398 - $34,269	32,330 Added 5.79%	590,294 $357,000
Q4 2021 Feb 14, 2022	BUY	$0.85 - $1.4 $248,259 - $408,898	292,070 Added 109.84%	557,964 $504,000
Q3 2021 Nov 12, 2021	BUY	$1.33 - $1.77 $339,408 - $451,693	255,194 Added 2384.99%	265,894 $354,000
Q2 2021 Aug 05, 2021	BUY	$1.41 - $1.94 $15,087 - $20,758	10,700 New	10,700 $15,000
Q4 2020 Feb 03, 2021	SELL	$1.55 - $2.24 $78,676 - $113,700	-50,759 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$1.91 - $3.08 $33,654 - $54,269	17,620 Added 53.17%	50,759 $99,000
Q2 2020 Aug 11, 2020	BUY	$1.97 - $3.98 $65,283 - $131,893	33,139 New	33,139 $91,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.